Makale detayı · 2020 · article
SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients
Veri kaynağı ayrımı
- YÖKSİSYÖKSİS makale kaydı
- YÖKSİS dergi adıTURKISH JOURNAL OF BIOLOGY
- Katalog eşleşmesi (ISSN)Turkish Journal of Biology
- OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
- Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)
Özet
The novel coronavirus pneumonia, which was named later as coronavirus disease 2019 (COVID-19), is caused by the severe acute respiratory syndrome coronavirus 2, namely SARS-CoV-2. It is a positive-strand RNA virus that is the seventh coronavirus known to infect humans. The COVID-19 outbreak presents enormous challenges for global health behind the pandemic outbreak. The first diagnosed patient in Turkey has been reported by the Republic of Turkey Ministry of Health on March 11, 2020. In May, over 150,000 cases in Turkey, and 5.5 million cases around the world have been declared. Due to the urgent need for a vaccine and antiviral drug, isolation of the virus is crucial. Here, we report 1 of the first isolation and characterization studies of SARS-CoV-2 from nasopharyngeal and oropharyngeal specimens of diagnosed patients in Turkey. This study provides an isolation and replication methodology,and cell culture tropism of the virus that will be available to the research communities.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
27atıfOpenAlex · cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 40 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- 2021 Gene editing and RNAi approaches for COVID-19 diagnostics and therapeutics.Atıf 50 · OpenAlex
- 2021 Gene editing and RNAi approaches for COVID-19 diagnostics and therapeuticsAtıf 50 · OpenAlex
- 2021 Gene editing and RNAi approaches for COVID-19 diagnostics and therapeuticsAtıf 50 · OpenAlex
- 2020 Gene editing and RNAi approaches for COVID-19 diagnostics and therapeuticsAtıf 50 · OpenAlex
- 2022 Comparison of COVID‐19 laboratory diagnosis by commercial kits: Effectivity of RT‐PCR to the RT‐LAMPAtıf 49 · OpenAlex
- 2022 COMPARISON OF COVID-19 LABORATORY DIAGNOSIS BY COMMERCIAL KITS: EFFECTIVITY OF RT-PCR TO THE RT-LAMPAtıf 49 · OpenAlex
- 2020 Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infectionAtıf 49 · OpenAlex
- 2020 Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infectionAtıf 49 · OpenAlex
- 2020 Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infectionAtıf 49 · OpenAlex
- 2020 Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infectionAtıf 49 · OpenAlex